85 related articles for article (PubMed ID: 7555275)
1. Radiotherapy of midline malignant reticulosis.
Gong Y
Chin Med J (Engl); 1995 Jul; 108(7):542-3. PubMed ID: 7555275
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
Kim K; Chie EK; Kim CW; Kim IH; Park CI
Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
[TBL] [Abstract][Full Text] [Related]
3. Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.
Shikama N; Izuno I; Oguchi M; Gomi K; Sone S; Takei K; Sasaki S; Wako T; Itou N; Ishii K
Radiology; 1997 Aug; 204(2):467-70. PubMed ID: 9240537
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.
Tham IW; Lee KM; Yap SP; Loong SL
Head Neck; 2006 Feb; 28(2):126-34. PubMed ID: 16240328
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
6. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy alone for nasal natural-killer/T-cell lymphoma.
Bahl G; Laskar S; Muckaden MA
J Clin Oncol; 2006 Jun; 24(17):2684-5; author reply 2685-6. PubMed ID: 16763286
[No Abstract] [Full Text] [Related]
8. [Nasal T lymphoma].
Díaz Sastre MA; Padilla Parrado M; Morales Puebla JM; Chacón Martínez J; Jiménez Antolín JA; Caro García MA; Galán Morales JT; Menéndez Loras LM; Orradre Romeo JL
An Otorrinolaringol Ibero Am; 2007; 34(4):329-41. PubMed ID: 17844952
[TBL] [Abstract][Full Text] [Related]
9. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy].
Tamai Y; Imataki O; Abe Y; Hagiwara S; Ito I; Asakura H; Harada H; Kamata M; Nishimura T; Kawakami K
Gan To Kagaku Ryoho; 2006 May; 33(5):687-90. PubMed ID: 16685174
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 53 cases of esthesioneuroblastoma].
Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
[TBL] [Abstract][Full Text] [Related]
15. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
16. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
Nie DH; Hu WH; Gao YH; Wu Y; Zhang SP
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):312-4. PubMed ID: 15312373
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity.
Jang NY; Wu HG; Park CI; Heo DS; Kim DW; Lee SH; Rhee CS
Jpn J Clin Oncol; 2010 Jun; 40(6):542-8. PubMed ID: 20185459
[TBL] [Abstract][Full Text] [Related]
19. [Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2010 Jul; 51(7):500-7. PubMed ID: 20693769
[No Abstract] [Full Text] [Related]
20. Treatment of lethal midline granuloma type nasal T-cell lymphoma.
Sakata K; Hareyama M; Ohuchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A
Acta Oncol; 1997; 36(3):307-11. PubMed ID: 9208902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
